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Aortic Insufﬁciency in a Patient With
Left Ventricular Assist Device
Friend or FoeMichael Zacharias, DO, Ravi Dhingra, MD, MPHA 29-year-old man with congenitally correctedtransposition of the great arteries underwentimplantation of a HeartMate II left ventricu-
lar assist device (LVAD) (Thoratec Corp, Pleasanton,
California) as a result of worsening systemic right
ventricular failure and New York Heart Association
class IV symptoms, as a bridge to transplant. After
6 months, he presented with atrial arrhythmias
and abdominal bloating. A repeat transthoracic echo-
cardiogram demonstrated severe continuous aorticFIGURE 1 Chest X-Ray
The chest x-ray shows (A) stable position post-deployment and (B) migr
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was referred to the cardiac catheterization laboratory
for a hemodynamic assessment and possible use of an
Amplatzer Septal Occluder (AGA Medical, Plymouth,
Minnesota) for closure of his aortic valve. Right heart
catheterization hemodynamics showed a right atrial
pressure of 16 mm Hg, pulmonary artery pressure
of 49/22 mm Hg, and pulmonary wedge pressure
of 18 mm Hg. Via the right femoral artery, a
30-mm Amplatzer atrial septal cribriform device wasation the following day. Red arrows indicate septal occluder position.
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FIGURE 2 CT Scan of the Chest
The computed tomography (CT) scan of the chest shows the Amplatzer Septal Occluder
(red arrow) partially overlying the left ventricular assist device inﬂow cannula.
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751advanced across the aortic valve and positioned
under transesophageal echocardiogram guidance. To
and fro motion was performed to test stability, and
the device appeared secure with minimal residual
aortic insufﬁciency. The device was released and
stayed in a stable position, which was also conﬁrmed
by chest x-ray (Figure 1A). This technique has been
previously described with success through a femoral
(1) and subclavian (2) approach. The following day,
a chest x-ray demonstrated that the device had
migrated into the left ventricle (Figure 1B). An emer-
gent computed tomography scan of the chest was
performed that showed that the Occluder device had
migrated to the oriﬁce of LVAD inﬂow cannula
(Figure 2). The LVAD speed was reduced to prevent
the device from completely obstructing the LVAD
inﬂow cannula. Luckily, a donor heart became avail-
able on the same night, and the patient was success-
fully transplanted without any complications.
Although a Septal Occluder device has previously
been described to improve aortic insufﬁciency; it
does so with potential risk.
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